BTG has a portfolio of Interventional Medicine (IM) products that advance the treatment of liver tumours, emphysema, severe blood clots and varicose veins, and a Specialty Pharmaceuticals business focused on niche antidote therapies.
30 Nov 2015
A leading specialist healthcare company
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
A leading specialist healthcare company
- Published:
30 Nov 2015 -
Author:
Capital Access Team -
Pages:
2
BTG has a portfolio of Interventional Medicine (IM) products that advance the treatment of liver tumours, emphysema, severe blood clots and varicose veins, and a Specialty Pharmaceuticals business focused on niche antidote therapies.